Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirjam Langeveld

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|July 27, 2023
Early Risk Stratification for Natural Disease Course in Fabry Patients Using Plasma Globotriaosylsphingosine LevelsSanne J van der Veen, Mohamed El Sayed, Carla E M Hollak, et al.
Hepatology (Baltimore, Md.)|September 5, 2009
Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in miceNora Bijl, Milka Sokolović, Carlos Vrins, et al.
International Journal of Molecular Sciences|August 19, 2020
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry DiseaseSanne J van der Veen, Wytze J Vlietstra, Laura van Dussen, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 22, 2024
Monocyte and macrophage profiles in patients with inherited long-chain fatty acid oxidation disordersSanne G S Verberk, Nico Hahn, Daan Heister, et al.
JIMD Reports|November 18, 2020
Neonatal carnitine concentrations in relation to gestational age and weightLoek L Crefcoeur, Monique G M de Sain-van der Velden, Sacha Ferdinandusse, et al.
Journal of Inherited Metabolic Disease|February 17, 2026
Medicine Development and Access for Rare Diseases: Can We Do Better?Carla E M Hollak, Noa Rosenberg, Colinda Post, et al.
Frontiers in Neurology|August 10, 2023
Inherited metabolic disorders in adults: systematic review on patient characteristics and diagnostic yield of broad sequencing techniques (exome and genome sequencing)Elise A Ferreira, Mark J N Buijs, Robin Wijngaard, et al.
Journal of Inherited Metabolic Disease|April 29, 2018
Mucolipidosis type III, a series of adult patientsEsmee Oussoren, David van Eerd, Elaine Murphy, et al.
Advances in Experimental Medicine and Biology|September 13, 2011
Glycosphingolipids and insulin resistanceJohannes M Aerts, Rolf G Boot, Marco van Eijk, et al.
Metabolism: Clinical and Experimental|August 6, 2011
Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidationMirjam Langeveld, Sjoerd A A van den Berg, Nora Bijl, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Clinical Journal of the American Society of Nephrology : CJASN|July 27, 2023
Early Risk Stratification for Natural Disease Course in Fabry Patients Using Plasma Globotriaosylsphingosine LevelsSanne J van der Veen, Mohamed El Sayed, Carla E M Hollak, et al.
Hepatology (Baltimore, Md.)|September 5, 2009
Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in miceNora Bijl, Milka Sokolović, Carlos Vrins, et al.
International Journal of Molecular Sciences|August 19, 2020
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry DiseaseSanne J van der Veen, Wytze J Vlietstra, Laura van Dussen, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 22, 2024
Monocyte and macrophage profiles in patients with inherited long-chain fatty acid oxidation disordersSanne G S Verberk, Nico Hahn, Daan Heister, et al.
JIMD Reports|November 18, 2020
Neonatal carnitine concentrations in relation to gestational age and weightLoek L Crefcoeur, Monique G M de Sain-van der Velden, Sacha Ferdinandusse, et al.
Journal of Inherited Metabolic Disease|February 17, 2026
Medicine Development and Access for Rare Diseases: Can We Do Better?Carla E M Hollak, Noa Rosenberg, Colinda Post, et al.
Frontiers in Neurology|August 10, 2023
Inherited metabolic disorders in adults: systematic review on patient characteristics and diagnostic yield of broad sequencing techniques (exome and genome sequencing)Elise A Ferreira, Mark J N Buijs, Robin Wijngaard, et al.
Journal of Inherited Metabolic Disease|April 29, 2018
Mucolipidosis type III, a series of adult patientsEsmee Oussoren, David van Eerd, Elaine Murphy, et al.
Advances in Experimental Medicine and Biology|September 13, 2011
Glycosphingolipids and insulin resistanceJohannes M Aerts, Rolf G Boot, Marco van Eijk, et al.
Metabolism: Clinical and Experimental|August 6, 2011
Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidationMirjam Langeveld, Sjoerd A A van den Berg, Nora Bijl, et al.
Pageof 8